Ioannis Avgerinos

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Diabetes, obesity & metabolism

Diabetologia

Annals of internal medicine

Current diabetes reviews

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Jun 01 2017

Greece

Research Fellow :: Clinical Research and Evidence-Based Medicine Unit, Second Medical Department

Publications

Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Ioannis Avgerinos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Aris Liakos, Thomas Karagiannis, Ioannis Avgerinos, Apostolos Tsapas, Apostolos Tsapas
Burden and Coping Strategies of Hypoglycemia in People with Diabetes. Current diabetes reviews (2023)
Ioannis Avgerinos, Thomas Karagiannis, Aris Liakos, Apostolos Tsapas, Apostolos Tsapas
Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis. Diabetes, obesity & metabolism (2022)
Thomas Karagiannis, Ioannis Avgerinos, Aris Liakos, Stephano Del Prato, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia 65 (8) (2022)
Ioannis Avgerinos, Apostolos Manolopoulos, Theodoros Michailidis, Konstantinos Kitsios, Aris Liakos, Thomas Karagiannis, Konstantinos Dimitrakopoulos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (3) (2021)
Ioannis Avgerinos, Georgia Papanastasiou, Thomas Karagiannis, Theodoros Michailidis, Aris Liakos, Maria Mainou, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 23 (10) (2021)
Ioannis Avgerinos, Thomas Karagiannis, Panagiota Kakotrichi, Theodoros Michailidis, Aris Liakos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 24 (1) (2021)
Apostolos Tsapas, Thomas Karagiannis, Panagiota Kakotrichi, Ioannis Avgerinos, Chrysanthi Mantsiou, Georgios Tousinas, Apostolos Manolopoulos, Aris Liakos, Konstantinos Malandris, David R Matthews, Apostolos Tsapas
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (9) (2021)
Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, David R Matthews
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes. Annals of internal medicine 174 (1) (2021)
Chrysanthi Mantsiou, Thomas Karagiannis, Panagiota Kakotrichi, Konstantinos Malandris, Ioannis Avgerinos, Aris Liakos, Apostolos Tsapas, Apostolos Tsapas
Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)
Apostolos Tsapas, Ioannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, Apostolos Manolopoulos, Panagiotis Andreadis, Aris Liakos, David R Matthews, Eleni Bekiari
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Annals of internal medicine 173 (4) (2020)
Ioannis Avgerinos, Theodoros Michailidis, Aris Liakos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (3) (2019)
Ioannis Avgerinos, Aris Liakos, Apostolos Tsapas, Apostolos Tsapas
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin. Diabetes, metabolic syndrome and obesity : targets and therapy 12 (2019)
Panagiotis Andreadis, Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Aris Liakos, Apostolos Manolopoulos, Apostolos Tsapas, David R Matthews, Apostolos Tsapas
Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes, obesity & metabolism 20 (9) (2018)
Ioannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, Aris Liakos, Maria Mainou, Apostolos Tsapas, David R Matthews, Apostolos Tsapas
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 21 (1) (2018)

Ioannis Avgerinos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ioannis Avgerinos